The following is a summary of "Bronchiectasis In Patients With Inflammatory Bowel Diseases – Prevalence, Predictors, And ...

Once activated, neutrophils release neutrophil serine proteases (NSPs), including neutrophil elastase (NE), which are considered central to the pathophysiology of bronchiectasis. Elevated levels ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...